To analyze the effect of chronic endogenous cortisol excess on the gut microbiome in patients with Cushing's syndrome (CS) and its implications for long-term health.
Key Findings:
Patients with active CS exhibited a disturbed gut microbiome profile compared to lean references, indicating potential metabolic implications.
Microbial dysbiosis persisted in CS patients even after achieving biochemical remission post-surgery, suggesting long-term health risks.
Distinct microbial profiles in CS patients suggest potential targets for probiotic interventions to restore gut health.
Interpretation:
The findings indicate that hypercortisolism may cause lasting changes in the gut microbiome, which could contribute to ongoing health issues post-remission, highlighting the need for targeted interventions.
Limitations:
Small sample size of CS patients may limit generalizability and statistical power.
Lack of data on eating habits could influence microbiome analysis and results.
Conclusion:
The study highlights the need for further research on the gut microbiome's role in Cushing's syndrome and its potential as a therapeutic target, emphasizing the urgency for longitudinal studies.
by German Rubinstein, Ilias Lagkouvardos, Evangelia Intze, Andrea Osswald, Stephanie Zopp, Leah Theresa Braun, Adriana Albani, Heike Künzel, Anna Riester, Felix Beuschlein, Martin Reincke, Katrin Ritzel
